Spring 2017 Seminar Series

Tuesday, January 10, 2017 – WIMR conference room 7001A
Visual Cognitive Disorders

  • Ari Rosenberg, PhD (Neuroscience)
    A computational perspective on altered visual cognition in autism
  • Yuri Saalmann, PhD (Psychology)
    Thalamic dysfunction in cognitive control disorders

Tuesday, February 14, 2017 – Genetics/Biotechnology Center room 1360
Ocular Biology/Pathology in the Lens and Cornea

  • Anne Griep, PhD (Cell and Regenerative Biology)
    Factors regulating cell structure and tissue organization in the lens
  • Sakae Ikeda, DVM (Medical Genetics)
    Abnormal cell proliferation and neovascularization in the cornea

Tuesday, March 14, 2017 – WIMR II conference room 3571
Mitochondrial Dynamics

  • Divya Sinha, PhD (Waisman Center, Gamm lab)
    Assessing mitochondrial integrity and function in human induced pluripotent stem cell-­‐derived RPE
  • Wei-­‐Hua Lee, PhD (Medical Genetics, Ikeda lab; Walsh Research Travel Award recipient)
    Mouse Tmem135 mutation reveals a mechanism involving mitochondrial dynamics that leads to age-­‐dependent retinal pathologies

Tuesday, April 11, 2017 – Genetics/Biotechnology Center room 1360
Canine Spontaneous Ocular Disorders and Parallel Human Diseases

  • Leandro Teixeira, DVM, MSc, ACVP (Director, COPLOW; Pathobiological Sciences)
    Chronic optic nerve axon loss and retinal atrophy in primary myelin disorders:
    What can a canine model tell us about monitoring MS progression by OCT?
  • Gillian Shaw, DVM, MS, PhD, DACVP (COPLOW; Pathobiological Sciences)
    Pleomorphic iridociliary adenocarcinomas in dogs

Tuesday, May 16, 2017 – WIMR II conference room 3571
Instrumentation Tools: Function and Composition of the Retina

  • James Ver Hoeve, PhD (Ophthalmology and Visual Sciences)
    Electrophysiology of vision: Role in novel drug development
  • Carol Hirschmugl, PhD (Physics, UW-­‐Milwaukee)
    Oxidative stress in diabetic retinopathy: imaging reveals histopathology

*Sponsored by EyeKor, Inc. and Ocular Services on Demand (OSOD), LLC, partnering with industry to accelerate the development of new therapies for ocular diseases. www.EyeKor.com and www.OcularServices.com